menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

ECHO™ A CME Self-Study Activity: Adoptions Barriers for High-Risk HPV (hrHPV) Primary Testing for Cervical Cancer Screening

ECHO™ A CME Self-Study Activity: Adoptions Barriers for High-Risk HPV (hrHPV) Primary Testing for Cervical Cancer Screening

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    More than 38,000 HPV-associated cancers occur in the United States each year affecting approximately 23,000 women. With cervical cancer being the most common HPV-associated cancer among women, it is important for physicians to understand the underlying data supporting the FDA decision on hrHPV primary testing for cervical cancer screening, and its relationship to current harmonized guidelines.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty

    Mark H. Einstein, MD, MS, FACS, FACOG
    Professor and Chair
    Department of Obstetrics, Gynecology & Women's Health
    Assistant Dean, Clinical Research Unit, Rutgers - NJMS
    Department of Obstetrics, Gynecology & Women's Health
    Newark, NJ

    Financial Disclosure:
    Advisor: Immunovaccine, Inovio, Natera, Papivax, PDS Biotechnologies, Photocure
    Contracted Research: Baxalta, Becton-Dickinson, Eli Lilly, Fujiboro, Inovio, PDS Biotechnologies, Pfizer, Photocure

    Reviewers/Planners/Authors

    • Sean T. Barrett, CHCP has nothing to disclose.
    • Kenneth Brown has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Kia K. Gray, MPH has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Jennifer Spear Smith, PhD has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Understand the underlying data supporting the FDA decision on hrHPV primary testing for cervical cancer screening, and its relationship to current harmonized guidelines
  • Target Audience

    This activity is designed to meet the educational needs of obstetricians, gynecologists, primary care physicians, nurse practitioners, physician assistants, and certified nurse midwives.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from Roche Diagnostics.

  • Disclaimer

    All rights reserved. No part of this publication may be reproduced without written permission from the publisher.

    The material presented in this Omnia Education continuing medical education activity does not necessarily reflect the views and opinions of Omnia Education. Neither Omnia Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.